Lung Cancer Research
Research provides hope and save lives. This is especially true when it comes to lung cancer research. Lung cancer research helps us understand how lung cancer is caused, how it develops how it might be prevented, how it is detected it and how the various types are best treated. Research can provide a better and longer future for those diagnosed with lung cancer as well as increase the number of survivors currently living with the disease.
However, more lung cancer research is needed as not all our questions about lung cancer have been answered. Lung cancer still remains the leading cause of cancer deaths, claiming more lives each year than breast, colon and prostate cancers combined. Yet lung cancer receives significantly less research funding than these other cancers.
The American Lung Association is committed to funding lung cancer research. As part of our Awards and Grants Program, a large part of funds go toward research on lung cancer prevention and treatment. The primary goal of this lung cancer research program is simple: improve and save lives. The secondary goal is just as important: To fund top-notch lung cancer researchers at important career crossroads to and gain long-term commitment to lung cancer research. Without the life-long dedication of lung cancer researchers, important and much needed discoveries would be impossible.
Thanks to the medical breakthroughs led by Lung Association researchers and their colleagues worldwide, our lung cancer researchers have made significant contributions to the field of lung cancer. Below are some of our current lung cancer researchers and their studies. Learn more about our current lung cancer research studies at Research Awards Nationwide.
"This research will hopefully lead to much needed treatments for NSCLC and could not have been possible without the support of the American Lung Association."
– Ramesh Ganju, PhD, ALA Lung Cancer Discovery Award Recipient 2013-2015
- Ankit Bharat, MDThe Role of Carbon Dioxide in Stopping Lung Healing After Lung Cancer Surgery
- Emily Cheng, MD, Ph DOvercoming Resistance to Newest EGFR-Inhibiting Lung Cancer Drugs
- Eric Collisson, MDUsing Genomics to Attack Lung Cancer
- Kristina Crothers, MDImproving How We Implement Lung Cancer Screening in Diverse Patient Populations
- Tushar Desai, MD, MPHGenetic Tools Help Shed Light on Lung Cancer Progression
- Anthony Faber, PhDResensitizing Cells to Lung Cancer Targeted Therapy
- Lida Hariri, MDDoes Tumor Environment Promote Drug Resistance in Lung Cancer Cells?
- Humam Kadara, PhDChanges in Airway Could Signal Early Lung Cancer Development
- Peter Kaiser, PhDDrugs to Reactivate Tumor-Killing Ability of p53
- Ji Yeon Kim, PhDLung Cancer Mutations Increase Levels of Polyamines
- Wenyu Liu, PhDPreventing Lung Cancer Stem Cells From Self-Renewinglung cancer, new jersey
- Yutaka Maeda, DVM, PhDEradicating Every Last Lung Cancer Cell
- Nancy McNamara, OD, PhDInhibiting a Protein Might Help Prevent or Treat Lung Cancer
- Sweta Mishra, PhDDiscovering Protein's Role in Resistance to Lung Cancer Chemotherapy
- John Poirier, PhDMolecular Mechanisms of Acquired Drug Resistance in Small Cell Lung Cancer
- Linda Resar, MDTherapy Blocks Protein Involved in Lung Cancer Growth
- Sameek Roychowdhury, PhD, MDIdentifying Gene Mutations in Lung Cancer That Can Be Attacked With Smart Drugs
- David Shackelford, PhDCompound May Kill Tumors With LKB1 Gene Mutation
- Samir Soneji, PhDDoes the Effectiveness of CT Screening Translate into Real-World Benefits?
- Eric Sweet-Cordero, MDExamining Cell-to-Cell Communication for Clues about Lung Cancer
- Seyedtaghi Takyar, MD, PhDEnhancing the Targeting of Tumor Blood Vessels in Lung Cancer
- Phuoc Tran, MD, PhDTargeting a Gene Involved in Lung Cancer Drug Resistance
- Narendra Wajapeyee, PhDTargeting p53 Gene to Treat Lung Cancer
- Guanghu Wang, PhDFighting Drug Resistance in Lung Cancer
- Johnathan Whetstine, PhDEnzyme Could Help Predict Effectiveness of Lung Cancer Chemotherapy